About TMS Therapy

TMS – Transcranial Magnetic Stimulation Therapy

TMS (transcranial magnetic stimulation) therapy has been recommended by the American Psychiatric Association since 2010 for treatment of major depressive disorder and approved by the UK National Institute of Health and Care Excellence (NICE) in 2015.
During treatment, magnetic pulses are delivered through a magnetic coil to stimulate nerve cells in the parts of the brain controlling the mood. Repeated stimulation of this area of the brain can have an antidepressants effect on people suffering from major depressive disorder.

About TMS Therapy

Since the 1980s, Transcranial Magnetic Stimulation (TMS) has been used to study the nerve fibers that carry information about movements from the brain to the spinal cord and on to the muscles. In the late 1990s, physicians began to explore the therapeutic potential of TMS for the treatment of a variety of diseases, with depression being the most thoroughly studied to date. Since then, more than 20 randomized, controlled trials studying TMS as a treatment for depression have been published by researchers throughout the world.

TMS Therapy is:

Non-invasive, meaning that it does not involve surgery. It does not require any anesthesia or sedation, as the patient remains awake and alert during the treatment.

Non-systemic, meaning it does not affect other areas of the body like medications can.

How Does TMS Work?

Through a treatment coil, the TMS Therapy system generates highly concentrated, magnetic fields that are rapidly switched on and off. These magnetic fields do not directly affect the whole brain; they only reach a few centimeters into the brain, directly beneath the treatment coil.

TMS or transcranial magnetic stimulation refers to a medical treatment that is delivered by a device that generates changing magnetic fields. There are many devices that can be used by clinicians. At present, in general, the devices are positioned over the area of the brain which has been targeted by the clinician. For depression, this area is the prefrontal cortex of the brain. These magnetic fields can create electrical activity in the nerve cells. At the present time, the mechanism of action is not known but could be related to this direct electric activity or indirect neurotransmitter effects in the brain. Regardless of the mechanism, it is well accepted by researchers and clinicians, that the magnetic stimulation affects not only the targeted area, the prefrontal cortex, but also the connected areas of the brain, the cingulate, amygdala, hypothalamus, and thalamus.

  • An alternative to antidepressants
  • Series of pulsed magnetic stimuli to the brain
  • FDA cleared* for the treatment of MDD
  • Non-invasive treatment – no anesthesia
  • Free from common antidepressant drug side effects
  • Does not affect cognitive function
  • Patients are able to resume daily activities right after treatment
  • May be used with or without antidepressant (determined by physician)
  • For use in outpatient settings
  • Maintenance treatment if needed

TMS for Depression

Olympia TMS has received FDA 510(k) clearance to market a 3 minute TBS (theta burst) protocol for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvements from prior antidepressant medication in the current episode. Olympia TMS is the only company to offer this revolutionary TBS protocol which will allow for a much higher patient throughput. We call it Express TMS®.

This faster TMS treatment is just as safe and effective for the treatment of major depressive disorder as standard TMS, only much faster. We are proud to be the first in the US to receive an FDA clearance for this revolutionary TMS treatment which is backed up by substantial scientific evidence.

Menu